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Introduction  
In November 2018, the Euro-Peristat collaboration published a new European Perinatal 
Health Report based on national-level indicators of mothers’ and babies’ health in 2015 in 
current EU member states and Iceland, Norway, and Switzerland, a total of 31 countries with 
over five million births (1). Euro-Peristat’s indicator set includes 10 core and 20 
recommended indicators of fetal and newborn health, maternal health, characteristics of the 
childbearing population and healthcare services (2). Indicators are compiled from 
population-based routine sources, such as civil registration systems, administrative or 
medical birth registers, audits and surveys (3).  A standardised protocol is used and 
integrates clinically relevant sub-groups, notably gestational age and birthweight. Each 
country provides aggregate data for all births at ≥ 22 completed weeks of gestation, or ≥500 
grams if gestational age is missing. If this is not possible, other clearly specified national 
criteria are used.  Euro-Peristat relies on the active involvement of national teams to 
compile, verify and interpret the indicators. Previous reports were produced for births in 
2000, 2004 and 2010 (2, 4). The 2015 report focuses on the core indicators and two 
recommended indicators relevant to public health, smoking in pregnancy and pre-pregnancy 
body mass index (BMI). 
In this commentary, over 50 graphs and tables in the 180 page report are distilled into a 
single table summarising the distribution of the principal Euro-Peristat indicators and risk 
ratios from meta-analyses comparing 2015 with 2010. These are used to support eight key 
messages for healthcare professionals, clinicians, policy makers and parents.    
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Key messages  
1. Wide disparities in fetal and neonatal mortality rates between countries exist 
and are not explained by reporting practices  
Comparisons of fetal, neonatal and infant mortality rates between countries are often met 
with scepticism because of questions about the consistency and completeness of reporting 
of deaths at the limits of viability (5, 6). Inclusion of terminations of pregnancy can also 
influence stillbirth rates (7). Many studies have shown that the size of artefactual reporting 
differences can outweigh expected true variation in rates (5-7). Table 1 illustrates the 
importance of using common gestational age thresholds. The median stillbirth rate was 2.7 
per 1000 when using the internationally recommended threshold of 28 weeks of gestation, 
but 3.4/1000, 26% higher, when using 24 weeks and 3.7/1000, 37% higher, when using 22 
weeks. This comparison also highlights the contribution of early stillbirths, which are 
excluded when the threshold of 28 weeks is used (5). Similar conclusions emerge for 
neonatal mortality rates: the median rate was 29% higher with a cut-off of 22 compared to 
24 weeks.  
Despite this impact on stillbirth and neonatal mortality rates, using common thresholds does 
not eliminate heterogeneity between countries.  With some exceptions, rankings are similar 
regardless of the threshold. Stillbirth rates ≥28 weeks’ gestation per 1000 total births ranged 
from below 2.3 in Cyprus, Iceland, Denmark, Finland, and the Netherlands to over 3.5 in 
Slovakia, Romania, Hungary, and Bulgaria. Greece, France, Sweden, Belgium and UK England 
and Wales were between these extremes with rates around 3.0. Neonatal mortality at ≥24 
weeks’ gestation ranged from under 1.3 per 1000 live births in Slovenia, Iceland, Finland, 
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Norway, the Czech Republic, Luxembourg and Estonia to around 2.0 in the Netherlands, 
Lithuania, France, Latvia and over 3.2 in Northern Ireland, Malta, Romania, and Bulgaria.  
2. Mortality rates were slightly lower in 2015 than in 2010, but some countries 
achieved greater reductions 
The stillbirth rate ≥28 weeks’ gestation in 2015 was 6% lower than in 2010 with a pooled risk 
ratio of 0.94 (95% CI: 0.89-0.99). This was less than the 17% reduction from 2004 to 2010 
(95% CI 10%-23%) observed in our previous report.(8) Neonatal mortality rates ≥24 weeks’ 
gestation in 2015 were 15% lower than in 2010 (95% CI: 9%-20%). This was also less marked 
than the 29% decrease (95% CI: 13%-36%) from 2004 to 2010. These slowdowns may reflect 
changing economic situations in many countries. 
Nonetheless, mortality rates were significantly lower in some countries. For stillbirths ≥28 
weeks, risk ratios of less than one were observed for the Netherlands (0.75, 95% CI: 0.65-
0.86), Scotland (0.79, 95% CI: 0.64-0.97), Poland (0.84, 95% CI: 0.77-0.91) and England and 
Wales (0.85, 95% CI 0.81-0.90), while Germany had a risk ratio over one (1.08, 95% CI: 1.01-
1.16). Neonatal mortality showed similar heterogeneity. Significant falls in some countries 
compared with stagnating rates elsewhere raise questions about whether health policies or 
practices played a role in mitigating the impact of socioeconomic adversity.   
3. Variations in preterm birth rates and trends raise questions about what drives 
population differences in this essential indicator of child health  
Preterm birth is associated with adverse child and adult health outcomes and its prevention 
is a major challenge in obstetrics. Our 2015 report confirms previous Euro-Peristat findings 
showing marked disparities in preterm birth rates and trends in Europe (9) and stresses the 
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need to understand these differences between countries. The median preterm live birth rate 
in 2015 was 7.3%, but ranged from less than 6% in Finland, Latvia, Estonia, Sweden, and 
Lithuania to more than 8% in Belgium, Scotland, Romania, Germany, Hungary, Greece, and 
Cyprus. A two-percent difference is substantial, representing over 77 000 fewer preterm 
children if all European countries reduced their preterm birth rates to at least 6%.   
Our data suggest that change is possible. Overall, preterm birth rates in 2015 did not differ 
from those in 2010, but this obscures significantly lower rates in six countries (the 
Netherlands, Austria, the Czech Republic, Spain, Sweden and Germany) and significantly 
higher in eight (Italy, Portugal, England and Wales, Poland, Ireland, France, Cyprus and 
Scotland). Understanding what drives these changes is an important public health priority.  
4. Limitations of public health surveillance systems impede valid comparisons of 
maternal mortality  
Euro-Peristat compiles data about maternal deaths over a five-year period (2011-2015) 
because the numbers are low. As well as data from routine systems, it draws on enhanced 
systems which use reinforced ascertainment methods, including data linkage and audits. 
Unfortunately, most countries rely solely on routine cause of death statistics even though 
they  under-ascertain maternal deaths (10). Data from countries with both routine and 
enhanced systems illustrate the extent of under-ascertainment. In Italy, enhanced reporting 
yields a maternal mortality ratio (MMR) of 9.7 versus 3.6 per 100,000 live births for routine 
data, whereas in Ireland, these figures are 9.2 and 2.6, respectively.  Given the feasibility of 
linking data about deaths and births, a minimum requirement for all countries should be to 
reinforce ascertainment using linkage. In addition, countries should consider implementing 
audits. There are excellent European models for these, such as the longstanding confidential 
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enquiries in the UK and France (10).  Meanwhile, data from routine systems should be 
interpreted cautiously. 
 
5. Disparities in caesarean section have widened, with rates reaching very high 
levels in some countries  
The median caesarean birth rate in 2015 was 27.0%. It ranged from below 18% in Iceland, 
Finland, Norway, and the Netherlands to over 30% in Slovakia, Ireland, Malta, Germany, 
Scotland, Luxembourg, Portugal, Switzerland and Italy. The highest rates were in Hungary 
(39.0%), Poland (42.2%), Bulgaria (43.0%), Romania (46.9%) and Cyprus (56.9%).  On average, 
rates in 2015 were 4% higher than in 2010, but this includes larger increases in Romania 
(36.9% to 46.9%), Poland, (34.0% to 42.2%), Hungary (32.3% to 39.0%), and Scotland (27.8% 
to 32.5%) and decreases in Lithuania, Latvia, Portugal, Estonia, Italy, and Norway. Euro-
Peristat also compiles caesarean rates by presentation, multiplicity, parity, gestational age, 
and previous caesarean. Rates in sub-groups tend to reflect overall caesarean rates (11);  for 
instance, the median caesarean rate for breech presentations was 89%, but it was under 
75% in Norway, Latvia, Finland, and France where overall caesarean rates are relatively low.  
6. Europe encompasses exemplary models for the care of pregnant women and 
newborns  
Data from this report identify high performers with good outcomes for fetal and neonatal 
mortality and low preterm birth and obstetric intervention rates. These shape a framework 
for goal setting. At a time when caesarean section rates are rising worldwide (12), these 
European models are needed to counter beliefs that caesarean rates should be increased to 
reduce fetal and neonatal mortality. Our report shows that low mortality rates can be 
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achieved with low caesarean rates, as in the Nordic countries, the Netherlands and Slovenia. 
While increasing obstetric intervention may be one way of lowering stillbirth rates, our data 
suggest that other options exist. For instance, stillbirth rates were lower in 2015 than in 
2010 in both the Netherlands and in the countries of the UK, but in England the caesarean 
rate rose by 10% from 2010, reaching 27.0% in 2015, while in the Netherlands, the 
caesarean rate was 17.4% in 2015, only 2% higher than in  2010.  
7. The childbearing population is diverse in Europe, but countries face common 
trends 
The percentages of births to women aged 35 years or more exceeded 29% in Portugal, 
Greece, Ireland, Italy, and Spain, twice as high as in Bulgaria, Romania, and Poland.  Smoking 
during pregnancy also varied; in a quarter of the 20 countries with data, more than 12.5% of 
women smoked, reaching 18.3% in the Valencia region in Spain, 17.3% in Wales, 16.3% in 
France and 14.3% in Northern Ireland compared with under 5% in Norway, Sweden, and 
Lithuania. In the smaller number of countries reporting maternal pre-pregnancy BMI, obesity 
(BMI ≥ 30) ranged from 7.8% in Croatia to over 22% in Scotland and Wales. Nonetheless, 
there were common trends, with significant increases in maternal age in 25 countries, along 
with less smoking and more obesity. Understanding the population impact of changing risk 
factors among childbearing women is essential for developing prevention policies and all 
countries should collect these data.   
8. High quality reporting of perinatal health indicators is possible, but lack of 
sustainability constrains its full potential  
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Euro-Peristat’s reports illustrate the feasibility of compiling comparable perinatal data, but 
also the limitations of the current system of relying on a project network of researchers and 
data providers. As rates fluctuate from year to year, continuous time series data are needed 
to fully monitor trends. Comprehensive reporting should also include all Euro-Peristat 
recommended indicators; these cover a wider set of health, healthcare and social factors, 
including mothers’ level education and countries of birth.  A sustainable infrastructure for 
data collection and analysis is needed to compile this fuller range of data. This challenge is 
addressed by the European Joint Action on Health Information (InfAct) which is seeking to 
improve the use of routine data for surveillance, research and policy in Europe. 
Conclusion 
European countries provide a rich terrain for comparing perinatal health indicators, given 
high standards of living, universal access to health care and widespread access to clinical 
knowledge, combined with diverse approaches to the care of pregnant woman and their 
babies. Euro-Peristat’s comparisons challenge health professionals and policy makers to 
confront shortcomings in their own countries and raise broader questions about the 
differences in health and health practices which this cross-country context makes visible. 
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Table 1: Summary of perinatal health indicators in Europe in 2015 and changes since 2010 
        Distribution (percentiles) Comparison with 2010 N of countries  
    N1 Median  Min 25th  75th  Max  N1 Risk ratio2 95% CI Higher3 Lower3 
C1 Fetal mortality rate (per 1000 total births)4            
 ≥22 weeks 33 3.7 2.4 3.4 4.4 7.3 29 0.93
 0.89 - 0.96 0 6 
 ≥24 weeks 33 3.4 1.8 3.0 3.8 6.9 27 0.93
 0.89 - 0.98 0 5 
 ≥28 weeks 33 2.7 1.4 2.4 3.1 5.7 30 0.94 0.89 - 0.99 1 4 
C2 Neonatal mortality rate (per 1000 live births)5            
 ≥22 weeks 33 2.2 0.7 1.8 2.7 4.4 30 0.90 0.85 - 0.94 1 9 
 ≥24 weeks 26 1.7 0.4 1.2 2.2 4.3 22 0.85 0.80 - 0.91 0 7 
C3 Infant mortality rate (per 1000 live births)            
 ≥22 weeks 33 3.1 1.5 2.3 3.8 7.6 28 0.88 0.84 - 0.93 0 8 
 ≥24 weeks 22 2.3 0.7 1.8 3.2 7.5 16 0.84 0.78 - 0.90 0 5 
C4 Percentage of low birthweight (<2500 g) births6 33 6.5 4.2 5.1 7.7 10.6 31 1.00 0.99 - 1.02 9 5 
C5 Percentage of preterm (<37 weeks GA) births7 33 7.3 5.4 6.5 7.8 12.0 31 1.02 0.99 - 1.04 8 6 
C6  Maternal mortality ratio (per 100,000 live births)            
 from routine statistical systems 23 4.9 0.0 3.6 6.3 24.7      
 from enhanced systems 7 8.9 5.1 8.1 9.5 12.9      
C7  
Multiple birth rate (per 1000 women delivering a live 
or still birth) 33 16.7 10.4 14.7 17.6 26.8 29 0.99 0.95 - 1.03 6 7 
C8 Distribution of maternal age             
 Percentage of women aged <20 years 33 2.1 0.8 1.4 3.5 10.2 31 0.78 0.72 - 0.83 2 25 
 Percentage of women aged ≥ 35 years 33 20.8 13.6 18.9 23.3 37.3 31 1.16 1.11 - 1.20 25 3 
C9 Percentage of primiparous mothers  33 47.4 38.2 42.5 49 54.5 29 0.98 0.97 - 0.99 4 10 
C10 Distribution of mode of delivery8            
 Percentage of caesarean deliveries 33 27.0 16.1 21.3 32.7 56.9 31 1.04 1.00 - 1.08 17 7 
 Percentage of instrumental delivery 29 7.2 0.5 3.5 10.9 15.1 27 1.03 0.99 - 1.07 8 8 
R8 Percent of women smoking during pregnancy 22 8.4 3.6 6.5 12.5 18.3 19 0.87 0.80 - 0.95 2 10 
R12 Percent of women with BMI ≥ 309 15 13.2 7.8 11.7 17.6 25.6 9 1.15 1.08 - 1.22 7 1 
Notes: (1) The UK provided some data separately for England and Wales, Scotland and Northern Ireland. Not all countries provided data in the 2010 report, explaining lower 
numbers of countries (2) Random effects pooled risk ratio, calculated with the method of DerSimonian and Laird; These analyses generate a pooled estimate which can be 
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interpreted as the risk ratio in an average country in Europe (3) Risk ratio for 2015 compared to 2010 is significantly different from 1, see forest plots in report (4) Without 
termination of pregnancy, when possible, however, for trends over time data on terminations are included because they were not removed in 2010 data. (5) Cohort data 
are used in 2015, when possible (6) The full indicator is the distribution of birthweight in 500 gram intervals, please see the report for further details (7) The full indicator is 
the distribution of gestational age in completed weeks, please see the report for further details; (8) Data are collected by key risk sub-groups: parity, presentation, 
multiplicity, gestational age, previous caesarean (9) The full indicator is the distribution of maternal BMI using the WHO classification.  
 
 
 
 
 
 
